BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26800386)

  • 1. Long-term cancer risk after hysterectomy on benign indications: Population-based cohort study.
    Altman D; Yin L; Falconer H
    Int J Cancer; 2016 Jun; 138(11):2631-8. PubMed ID: 26800386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian cancer risk after salpingectomy: a nationwide population-based study.
    Falconer H; Yin L; Grönberg H; Altman D
    J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25628372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hysterectomy and risk of cardiovascular disease: a population-based cohort study.
    Ingelsson E; Lundholm C; Johansson AL; Altman D
    Eur Heart J; 2011 Mar; 32(6):745-50. PubMed ID: 21186237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid cancer after hysterectomy on benign indications: Findings from an observational cohort study in Sweden.
    Falconer H; Yin L; Bellocco R; Altman D
    Int J Cancer; 2017 Apr; 140(8):1796-1801. PubMed ID: 28103650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study.
    Obermair A; Youlden DR; Baade PD; Janda M
    Int J Cancer; 2014 May; 134(9):2211-22. PubMed ID: 24127248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pelvic organ prolapse surgery following hysterectomy on benign indications.
    Altman D; Falconer C; Cnattingius S; Granath F
    Am J Obstet Gynecol; 2008 May; 198(5):572.e1-6. PubMed ID: 18355787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998-2011.
    Mikhail E; Salemi JL; Mogos MF; Hart S; Salihu HM; Imudia AN
    Am J Obstet Gynecol; 2015 Nov; 213(5):713.e1-13. PubMed ID: 25935772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review.
    Evans EC; Matteson KA; Orejuela FJ; Alperin M; Balk EM; El-Nashar S; Gleason JL; Grimes C; Jeppson P; Mathews C; Wheeler TL; Murphy M;
    Obstet Gynecol; 2016 Sep; 128(3):476-85. PubMed ID: 27500347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Health Consequences After Ovarian Removal at Benign Hysterectomy : A Nationwide Cohort Study.
    Gottschau M; Rosthøj S; Settnes A; Aalborg GL; Viuff JH; Munk C; Jensen A; Kjær SK; Mellemkjær L
    Ann Intern Med; 2023 May; 176(5):596-604. PubMed ID: 37068275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oophorectomy and hysterectomy and cancer incidence in the Cancer Prevention Study-II Nutrition Cohort.
    Gaudet MM; Gapstur SM; Sun J; Teras LR; Campbell PT; Patel AV
    Obstet Gynecol; 2014 Jun; 123(6):1247-1255. PubMed ID: 24807324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian removal at or after benign hysterectomy and breast cancer: a nationwide cohort study.
    Gottschau M; Kjær SK; Settnes A; Aalborg GL; Bens A; Jensen A; Munk C; Mellemkjær L
    Breast Cancer Res Treat; 2020 Jun; 181(2):475-485. PubMed ID: 32328847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do breast cancer survivors benefit from prophylactic removal of uterus and ovaries? A population-based data linkage replication study.
    Obermair A; Youlden D; Baade P; Janda M
    Asia Pac J Clin Oncol; 2017 Feb; 13(1):68-78. PubMed ID: 27230709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential adverse effects of prophylactic bilateral salpingo-oophorectomy on skin aging in premenopausal women undergoing hysterectomy for benign conditions.
    Töz E; Özcan A; Balsak D; Avc ME; Eraslan AG; Balc DD
    Menopause; 2016 Feb; 23(2):138-42. PubMed ID: 26382316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of prophylactic hysterectomy in patients at high risk for hereditary cancers.
    Villella JA; Parmar M; Donohue K; Fahey C; Piver MS; Rodabaugh K
    Gynecol Oncol; 2006 Sep; 102(3):475-9. PubMed ID: 16473397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hysterectomy on benign indications in Sweden 1987-2003: a nationwide trend analysis.
    Lundholm C; Forsgren C; Johansson AL; Cnattingius S; Altman D
    Acta Obstet Gynecol Scand; 2009; 88(1):52-8. PubMed ID: 19140043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of hysterectomy on fistula formation in women with diverticulitis.
    Altman D; Forsgren C; Hjern F; Lundholm C; Cnattingius S; Johansson AL
    Br J Surg; 2010 Feb; 97(2):251-7. PubMed ID: 20035535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hysterectomy and risk of stress-urinary-incontinence surgery: nationwide cohort study.
    Altman D; Granath F; Cnattingius S; Falconer C
    Lancet; 2007 Oct; 370(9597):1494-9. PubMed ID: 17964350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hysterectomy and Risk of Breast, Colorectal, Thyroid, and Kidney Cancer - an Australian Data Linkage Study.
    Wilson LF; Tuesley KM; Webb PM; Dixon-Suen SC; Stewart LM; Jordan SJ
    Cancer Epidemiol Biomarkers Prev; 2021 May; 30(5):904-911. PubMed ID: 33619026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of normal ovaries in women under age 51 at the time of hysterectomy.
    Karp NE; Fenner DE; Burgunder-Zdravkovski L; Morgan DM
    Am J Obstet Gynecol; 2015 Nov; 213(5):716.e1-6. PubMed ID: 26032038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.